Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioIndustry Association appoints new board of directors

This article was originally published in Scrip

Executive Summary

The BioIndustry Association (BIA) has appointed five new members to its board of directors: Dr John Brown, chairman of BTG and CXR Biosciences; Paul Drohan, general manager and vice-president of Genzyme UK and Ireland; Steven Harris, CEO of Circassia; Dr Ed Hodgkin, CEO of Biotica Technology; and Dr Sam Williams, CEO of Modern Biosciences. The BIA, which encourages and promotes the bioscience sector within the UK economy, also re-elected Kate Bingham, managing partner at SV Life Sciences; Tim Edwards, president and CEO of Cellzome; Dr Jeremy Haigh, vice-president and international chief operating officer, R&D, at Amgen; Geoff Newman, co-founder and managing director of Interea International; Ian Nicholson, CEO of Chroma Therapeutics; and Peter Nolan, executive director and senior vice-president of commercial development at Oxford BioMedica. All board members will serve from January 1st onwards.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC005298

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel